Dupont Capital Management Corp Spring Works Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$67.45 - $85.63 $383,453 - $486,806	-5,685 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$65.1 - $93.59 $75,971 - $109,219	-1,167 Reduced 17.03%	5,685 $418,000
Q4 2020 Jan 28, 2021	SELL	$48.36 - $77.92 $24,760 - $39,895	-512 Reduced 6.95%	6,852 $497,000
Q3 2020 Oct 29, 2020	BUY	$36.14 - $51.99 $266,134 - $382,854	7,364 New	7,364 $351,000

240

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.18B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.